MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. - Wikidata - wikimedia - TriplyDB

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

http://www.wikidata.org/entity/Q36150107

about

Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649).Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer.Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients.Effect of etoposide-induced alteration of the Mdm2-Rb signaling pathway on cellular senescence in A549 lung adenocarcinoma cells.A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population.Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon.Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.Effects of MDM2 promoter polymorphisms on the development of cervical neoplasia in a Southeastern Brazilian population.The Roles of MDM2 and MDMX in Cancer.

P2860

Q28066326-194A8469-BBB5-4C3A-8D31-CE9023B29F83 Q33932445-98CB887C-1124-4525-849F-3F541358732A Q34483516-1A3202F7-4749-429D-9C74-91ECF8A46B92 Q36945832-79902E28-7B78-4E30-AB63-20B39C1D9F29 Q37208141-1DA701DF-F2A8-458C-BE11-BF9889D9858F Q37254339-C135582B-5215-4F04-8031-9D2B8DF85207 Q37317626-42307587-4B01-49D0-ADF7-A2CCD5C29D35 Q38619011-0F6AF732-CCAF-42E1-9724-2C1E65CE5A37 Q41676857-E077DE90-1E3B-4569-BFE4-2B4D7CFB1B4A Q42148989-DEF8B454-737B-422E-8604-162DCF24263D Q45859705-5FFF8F95-3A07-44A3-9AE7-66047F38B6C8 Q53727895-ABEC9A09-3ADA-47AA-A6A5-994E809C9D2A Q54190110-F2A6AF9A-63BE-4512-9A99-905E8933422B Q55517350-05A5F41F-48C7-47A1-92A7-3E8D45BDD80F

P2860

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

http://www.wikidata.org/entity/Q36150107

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

@ast

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

@en

type

label

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

@ast

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

@en

prefLabel

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

@ast

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.

@en

P1433

Q36150107-961123B8-4F0C-40FB-9FBC-528C65FFB8FD

P1476

Q36150107-85129C68-AAB5-4CC6-A4D2-A2C762725679

P2093

Q36150107-084706CF-2C5F-4ADD-91AD-2A509ACAAE72

Q36150107-57A554AB-F90A-48A3-8DA0-F5A4E60E6369

Q36150107-9B33A026-BED2-4EA2-8FC2-1E448066708D

Q36150107-CF482EEF-7030-424F-9B4A-837D014B0AB5

Q36150107-F2B7C7FA-5E80-4FA6-A19C-1CF572ECC7BF

P2860

Q36150107-00339020-967B-4A7E-8DE5-A4621398FE68

Q36150107-00363379-BF53-4CC5-99F6-89ABF2A846F8

Q36150107-03C37343-1477-477C-90E2-E1FB2ED65030

Q36150107-05884016-5457-44C1-9E81-1B05D170A55F

Q36150107-15B02A34-2A6A-4978-A87A-256D62F2F997

Q36150107-1D9DC040-4C1C-4D6D-8118-ADA2828A7721

Q36150107-2DD752B3-249A-4762-949F-45A9776FD037

Q36150107-2EEAAB93-510A-4F20-8CFD-8856F8EF0511

Q36150107-3244F5EB-AD27-4494-853E-286D85803CCC

Q36150107-3DBE1E0A-FBC2-4F8B-B634-A109A6B8723F

P304

Q36150107-6EC1EF77-0858-410F-BDF5-728412AC9D79

P31

Q36150107-ACBE5CB9-BA66-4590-8535-45FA9E2AEC3A

P356

Q36150107-B6E772C1-8CFA-44C0-91FC-E7F71F99209F

P433

Q36150107-AC26AEED-11A6-47CB-B2C3-3BD8705BAE71

P478

Q36150107-48B3D2CB-021A-4D19-8FE5-9C47E1F9779F

P50

Q36150107-4864635A-ED63-419D-A9A8-854B05F93018

Q36150107-9F6359C3-EA05-42A3-8343-D53573C97092

P577

Q36150107-92945227-B6E0-4F2D-9060-0FF183454BA4

P5875

Q36150107-9C289FC1-9A2A-4FA3-BBE1-EE337F871DDB

P698

Q36150107-75EC51F9-85C7-419A-A7B3-BE000EB85538

P932

Q36150107-3A555A5B-0A0A-4103-BE60-2C977EA72206

P356

P1433

International Journal of Cancer

P1476

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer

@en

P2093

Ana I Robles

http://www.w3.org/2001/XMLSchema#string

Curtis C Harris

http://www.w3.org/2001/XMLSchema#string

Elise D Bowman

http://www.w3.org/2001/XMLSchema#string

Kara M Calhoun

http://www.w3.org/2001/XMLSchema#string

Sharon R Pine

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements

Cancer statistics, 2012

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.

Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore

The p53 orchestra: Mdm2 and Mdmx set the tone

Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis.

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

P304

2710-2716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.27573

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223969525

http://www.w3.org/2001/XMLSchema#string

P698

22487911

http://www.w3.org/2001/XMLSchema#string

P932

3414691

http://www.w3.org/2001/XMLSchema#string